Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids
George E. Magoulas,
Pantelis Afroudakis,
Kalliopi Georgikopoulou,
Marina Roussaki,
Chiara Borsari,
Theano Fotopoulou,
Nuno Santarem,
Emile Barrias,
Paloma Tejera Nevado,
Julia Hachenberg,
Eugenia Bifeld,
Bernhard Ellinger,
Maria Kuzikov,
Irini Fragiadaki,
Effie Scoulica,
Joachim Clos,
Sheraz Gul,
Maria Paola Costi,
Wanderley de Souza,
Kyriakos C. Prousis,
Anabela Cordeiro da Silva,
Theodora Calogeropoulou
Affiliations
George E. Magoulas
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Pantelis Afroudakis
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Kalliopi Georgikopoulou
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Marina Roussaki
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Chiara Borsari
Department of Biomedicine, University of Basel, 4058 Basel, Switzerland
Theano Fotopoulou
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Nuno Santarem
i3S–Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
Emile Barrias
Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
Paloma Tejera Nevado
Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany
Julia Hachenberg
Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany
Eugenia Bifeld
Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany
Bernhard Ellinger
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany
Maria Kuzikov
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany
Irini Fragiadaki
Department of Clinical Microbiology and Microbial Pathogenesis, Faculty of Medicine, University of Crete, 70013 Heraklion, Greece
Effie Scoulica
Department of Clinical Microbiology and Microbial Pathogenesis, Faculty of Medicine, University of Crete, 70013 Heraklion, Greece
Joachim Clos
Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany
Sheraz Gul
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany
Maria Paola Costi
Department of Pharmacy, Università degli Studi di Modena e Reggio Emilia, 41125 Modena, Italy
Wanderley de Souza
Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
Kyriakos C. Prousis
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
Anabela Cordeiro da Silva
i3S–Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal
Theodora Calogeropoulou
National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece
A library of seventeen novel ether phospholipid analogues, containing 5-membered heterocyclic rings (1,2,3-triazolyl, isoxazolyl, 1,3,4-oxadiazolyl and 1,2,4-oxadiazolyl) in the lipid portion were designed and synthesized aiming to identify optimised miltefosine analogues. The compounds were evaluated for their in vitro antiparasitic activity against Leishmania infantum and Leishmania donovani intracellular amastigotes, against Trypanosoma brucei brucei and against different developmental stages of Trypanosoma cruzi. The nature of the substituents of the heterocyclic ring (tail) and the oligomethylene spacer between the head group and the heterocyclic ring was found to affect the activity and toxicity of these compounds leading to a significantly improved understanding of their structure–activity relationships. The early ADMET profile of the new derivatives did not reveal major liabilities for the potent compounds. The 1,2,3-triazole derivative 27 substituted by a decyl tail, an undecyl spacer and a choline head group exhibited broad spectrum antiparasitic activity. It possessed low micromolar activity against the intracellular amastigotes of two L. infantum strains and T. cruzi Y strain epimastigotes, intracellular amastigotes and trypomastigotes, while its cytotoxicity concentration (CC50) against THP-1 macrophages ranged between 50 and 100 μM. Altogether, our work paves the way for the development of improved ether phospholipid derivatives to control neglected tropical diseases.